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Introduction: The aim of the present study was to compare the efficacy of 2% lidocaine to 
4% articaine in buccal infiltration of maxillary first molars with irreversible pulpitis. 
Moreover, the effect of root length on success of anesthesia irrespective of the type of 
anesthetic agent was assessed. Methods and Materials: Fifty patients suffering from painful 
maxillary first molars with irreversible pulpitis received an infiltration injection of either 4% 
articaine with 1:100000 epinephrine or 2% lidocaine with 1:80000 epinephrine. Each patient 
recorded their pain score in response to a cold test on a Heft-Parker visual analogue scale 
(VAS) before commencing the treatment, 5 min following injection, during access 
preparation, after pulp exposure and during root canal instrumentation. No or mild pain at 
any stage was considered a success. Data were analyzed using the multivariate logistic 
regression analysis, chi-square and t tests. Results: Finally, 47 out of 50 patients were eligible 
to be included in this study. The anesthetic success rates in the lidocaine and articaine groups 
were 56.52% and 66.67%, respectively and the difference was not significant (P=0.474). 
Irrespective of the anesthetic agent, the length of the palatal root (Odds Ratio=0.24, P=0.007) 
had an adverse effect on anesthetic success. There was an association between longer palatal 
root length and anesthetic failure. Conclusion: No significant difference was found between 
2% lidocaine and 4% articaine in terms of anesthetic success in maxillary first molars with 
irreversible pulpitis. The length of the palatal root had a significant negative influence on 
anesthetic success. 
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Introduction 
ain control during and after root canal treatment is an 
important subject that has attracted considerable attention 
[1-8]. One of the most important steps during root canal 
treatment of teeth with irreversible pulpitis is to provide 
profound anesthesia in order to prevent pain perception during 
the procedure [9]. Numerous investigations have focused on 
assessing different devices, different anesthetic agents, and 
supplemental anesthetic techniques to increase the ability of 
clinicians to overcome pain during treatment and to provide 
higher success rates of anesthesia [9-22]. Most of these 
investigations have been performed on mandibular teeth due to 
the perception that achieving anesthesia in mandibular teeth is 
much more difficult than their maxillary counterparts [9].  
Lidocaine is the most widely used dental anesthetic agent 
[23]. Articaine has been reported to be a superior anesthetic 
solution for infiltration injection. Several studies have 
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compared the efficacy of articaine and lidocaine following 
injection in the maxillary molar region [10, 13, 24-27]. The 
results of two meta-analyses favored the effectiveness of 
articaine over lidocaine for infiltration injection [28, 29]. 
However, most previous investigations these solutions are 
crossover studies and only three studies compared them for 
maxillary first molars with irreversible pulpitis. These studies 
reported conflicting results regarding the efficacy of the two 
anesthetic solutions [10, 26, 27]. Two of them reported no 
significance different between lidocaine and articaine [26, 27], 
whereas the other one reported a significantly higher anesthetic 
success when articaine was used [10]. 
Anesthetic success may depend on several variables such as 
the pulp status, the presence of inflammation in the pulp, and 
whether any anesthetic supplemental technique is used [9]. 
Another variable that might influence the efficacy of anesthesia 
is the root length [30]. In theory, injection of the anesthetic agent 
more coronally than the location of root apex might adversely 
affect the success of anesthesia. However, no study is available 
regarding the effect of root length on anesthesia of maxillary 
molars. Therefore, the aims of this study were firstly to compare 
the anesthetic efficacy of 2% lidocaine with 1:80000 epinephrine 
and 4% articaine with 1:100000 epinephrine on asymptomatic 
maxillary molars with irreversible pulpitis and secondly, to 
investigate the effect of root length on the efficacy of anesthesia 
irrespective of the type of anesthetic agent. 
Materials and Methods 
This study was approved by the Ethics Committee of Kerman 
University of Medical Sciences in Iran (KA.92.114) and Iranian 
Registry of Clinical Trials (ID: IRCT201204302016N5). The 
sample size calculation, which was based on type I error of 0.05 
and power of 0.8, indicated that ideally a sample size of 25 in 
each group would be required.  
The inclusion criteria used in this study were: healthy 
adult patients over 18 years of age having a first maxillary 
molar with asymptomatic irreversible pulpitis and normal 
periapical radiographic appearance. Pulp vitality was 
determined by a positive response to EPT (SybronEndo, 
Glendora, CA) and cold tests (Roeko Endo Frost, Roeko, 
Hangenav, Germany) and a diagnosis of asymptomatic 
irreversible pulpitis was made if a prolonged response to cold 
(more than 10 sec) was noted.  
The exclusion were the presence of systemic disorders, any 
known sensitivity to either 2% lidocaine or 4% articaine or 
epinephrine, the widening of periodontal ligament space, the 
presence of a periapical radiolucency, pregnancy, using any 
type of analgesics 12 h before the treatment, moderate to severe 
spontaneous pain, tenderness to percussion and having a tooth 
not suitable for simple restorative treatment because of 
extensive caries or periodontal problems. 
Fifty patients were eligible to participate in this prospective, 
randomized double-blind study. All patients were treated in 
the postgraduate clinic of the Endodontic Department of 
Kerman Dental School in Iran from Sep 2013 to Jan 2014. All 
subjects signed an informed consent form in which the nature 
of the procedure and the possible discomforts and risks were 
fully described. 
The patients were randomly divided into two groups of 25 
patients each. In order to randomize the patients, the number 
of patients in each group were written on paper and kept in a 
sealed box. The practitioner who administrated the local 
anesthesia chose one of the papers and based on the number, 
the patient was assigned to one of the groups. Another 
practitioner did the cold test and then prepared the access 
cavity after administration of the anesthetic agent. Therefore 
neither the second practitioner nor the patients were aware of 
the type of anesthetic agents used.  
Patients in group 1 were given a buccal infiltration injection 
of 1.8 mL 2% lidocaine with 1:80000 epinephrine (Persocaine-
E, Daru Pakhsh Pharmaceutical Mfg. Co., Tehran, Iran) and 
patients in group 2 had the same injection but with 1.8 mL of 
4% articaine with 1:100000 epinephrine (Artinibsa, Inibsa, 
Barcelona, Spain). 
Before injection, the patients were asked to rate their pain 
using a Heft-Parker visual analog pain scale (VAS) after the cold 
test. The VAS scores were divided into four categories. No pain 
corresponded to 0 mm, mild pain was defined as being in the 
range of 0< and <54 mm, moderate pain was defined as being 
<54 and <114, and severe pain was defined as being ≥114 mm. 
After applying topical anesthesia (20% Benzocaine; Premier, 
Philadelphia, PA, USA) to the site of the injection, a standard 
maxillary buccal infiltration was administered using an 
aspirating syringe with a side-loading cartridge system (Dena 
Instruments, Forgeman Instruments Co., Pakistan) and a 27-
gauge 25 mm needle (C-K ject, CK Dental, Kor-Kyungji-do, 
Korea). The injection site was between the estimated location of 
mesiobuccal and distobuccal root apices of the maxillary first 
molar. The needle was gently placed into the alveolar mucosa 
with the bevel toward the alveolar bone and penetrated until it 
was estimated to be above the apices of the buccal roots of the 
teeth. All injections were given by the same clinician. Five min 
after administering anesthesia, the teeth were again tested with 
the same cold pulp sensibility test and the patients were asked to 
rate their pain using the Heft-Parker VAS [31]. 
The teeth were then isolated with rubber dam and an 
endodontic access cavity was prepared. The patients were 
informed to rate any pain that they experienced during each step 
of access cavity preparation including cutting within dentin, 
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entering the pulp chamber or during root canal 
instrumentation. Absence of pain or mild discomfort was 
considered as success whereas moderate or severe pain was 
considered as failure of anesthesia. In case of sensitivity to the 
cold test before starting the access cavity or if pain was reported 
at any stage during treatment, another method of anesthesia 
(palatal infiltration, intra-ligamentary, and intra-pulpal 
injections as supplemental techniques) was employed to 
overcome the patients’ discomfort.  
In each tooth, for root canal measurement, at first the 
coronal third of all root canals were enlarged with #2 Gates 
Glidden drills (Mani, Tochigi, Japan) and then the root canal 
length was measured with Root ZX apex locator (J. Morita 
Corporation, Kyoto, Japan) with a #10 K-file (Mani, Tochigi, 
Japan). Then the root canal was instrumented until at least #15 
K-type file can be inserted to the full working length as measured 
by the apex locator. Then a periapical radiography was taken 
from the tooth. If the measurement was within ±1 mm from the 
radiographic apex, the file was adjusted into the root canal and 
another radiography was taken. Meanwhile, the root canal was 
again measured with the apex locator. After establishing the 
measurement, root canal instrumentation were completed with 
RaCe rotary instruments (FKG Dentaire, La Chaux-de-Fonds, 
Switzerland) with the same sequence of a previous investigations 
[1] and master gutta-percha cones were inserted into the root 
canals and another periapical radiograph was taken.  
Comparisons were done using the t-test for continuous 
variables and chi-square or Fischer’s exact test for categorical 
data. Multivariate logistic regression analysis was performed to 
identify variables that could be significant predictors of success 
in treatment. P-values less than 0.05 were considered as 
significant. 
Results 
At the final stage of the treatment, 47 out of 50 patients were 
found to be eligible for the study. Two patients (one each from 
the articaine and the lidocaine groups) were excluded because 
the pulp was not exposed while one patient from the lidocaine 
group was excluded because the pulp was partially necrotized 
noted after pulp exposure. No side effect was found among the 
patients after administration of anesthesia. 
There was no significant difference in gender and age 
between the two groups (P=0.45 and P=0.90, respectively). 
Final success of anesthesia was 56.52% for the lidocaine group 
and 66.67% for the articaine group (Table 1). There was no 
significant difference between the groups (P=0.47). 
Analysis of the distobuccal and mesiobuccal root lengths 
showed no significant influence on the efficacy of anesthesia 
irrespective of which anesthetic agent was used (P=0.72 and 
P=0.89, respectively) (Table 2). In contrast, the palatal root 
length had a significant influence on the efficacy of anesthesia 
meaning that shorter palatal roots showed significantly higher 
successful anesthesia than longer roots [Odds Ratio 
(OR)=0.24, P=0.007].  
 
Table 1. Number (percentage) of success and failure at various steps during access cavity preparation and root canal instrumentation 
 Success N (%) Failure N (%) 
P-Value 
Lidocaine Articaine Lidocaine Articaine 
5 min 23 (100) 22 (91.7) 0 (0) 2 (8.3) 0.489 
Dentin 21 (91.3) 22 (100) 2 (8.7) 0 0.489 
Pulp 17 (80.95) 21 (95.5) 4 (19.05) 1 (4.5) 0.185 
Filing 13 (76.47) 16 (76.2) 4 (23.53) 5 (23.8) 1.000 
Final Success 13 (56.52) 16 (66.67) 10 (43.48) 8 (33.33) 0.474 
Table 2. Factors associated with final success of anesthesia (OR=odds ratio) 
 Adjusted OR CI 95% P-value 
Age 1.20 0.99-1.45 0.058 
Sex 
Male 1 -- -- 
Female 0.097 0.01-1.64 0.106 
Group 
Lidocaine 1 -- -- 
Articaine 2.12 0.34-13.14 0.418 
Root 
Mesiobuccal 1.07 0.38-2.98 0.893 
Distobuccal 1.19 0.45-3.15 0.723 
Palatal 0.24 0.08-0.67 0.007 
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Discussion 
The results of the present study showed no significant 
difference between 4% articaine and 2% lidocaine on 
anesthetic success following an infiltration injection for 
maxillary first molars with irreversible pulpitis (P=0.47). In 
addition, the palatal root length significantly affected the 
anesthetic success, whereas the mesiobuccal and distobuccal 
root lengths had no significant influence on anesthesia, 
irrespective of the anesthetic agent used. 
The onset of anesthesia is an important issue for anesthesia 
success evaluation. The onset of anesthesia in inferior alveolar 
nerve block and infiltration injection are different and the 
letter technique provide quicker anesthesia [3, 9]. The onset of 
anesthesia in maxillary teeth is usually achieved within 5-7 min 
after administration of anesthesia [10, 25, 26, 32]. Therefore, 
in the present study, a cold pulp sensibility test was performed 
5 min after administration of anesthesia to initially test the 
effectiveness of the injection. 
In theory, during infiltration injection of maxillary molars 
the needle should penetrate deep enough inside the buccal 
tissues to deposit the anesthetic agent as close as possible to the 
root apex to increase anesthetic success [30]. This method is 
relatively simple for single-rooted teeth. However, for teeth 
with multiple roots such as maxillary first molars, the effect of 
root length on the efficacy of anesthesia has not been 
investigated previously. In the present study, the mesiobuccal 
and distobuccal root lengths showed no significant influence 
on the anesthetic success (P=0.893 and P=0.723, respectively), 
but the palatal root length did show a significant influence on 
the success of injection (OR=0.24, P=0.007). This is consistent 
with other studies that have reported a single buccal 
infiltration may not be effective for anesthetizing the palatal 
roots of maxillary molars [33, 34]. The major reason may be 
the distance between the site of injection and the root apex of 
the palatal root [30]. Thus, it is likely that maxillary molars 
with long or more divergent palatal roots may present 
anesthetic difficulties since the root apex is more distant from 
the injection site. Hence, from the clinical point of view, it can 
be recommended that if the pre-operative periapical 
radiography shows a molar tooth with long roots, then a 
supplemental injection should be considered before 
commencing access cavity preparation. 
Several investigations have been performed to evaluate 
anesthesia success for maxillary molars [10, 25-27, 33-42]. 
Previous investigations compared the efficacy of single buccal 
infiltration injections versus both buccal and palatal injections 
and have reported no significant difference [40, 41]. Since 
palatal injection provokes pain and discomfort for the patient 
[9] in the present study only a single buccal injection of the 
tested anesthetic agents were used.  
The results of the present study were in contrast with the 
results of two previously published meta-analyses that 
compared the efficacy of articaine with lidocaine following 
infiltration injection [28, 29]. However, both meta-analyses 
had two major shortcomings. Firstly, these analyses combined 
data from studies investigating anesthesia of irreversible 
pulpitis and normal pulps. It has been shown that the risk of 
anesthesia failure in teeth with irreversible pulpitis is much 
higher than those with normal pulps. Therefore including data 
from both types of studies for meta-analysis is inappropriate 
[9]. Secondly, both meta-analyses included studies that used 
articaine for mandibular and maxillary infiltration injections. 
From the anatomical stand point, the cortical plate at the molar 
region of the mandible is much thicker than in the maxilla [30] 
and this can inhibit infiltration of the anesthetic agent. 
Therefore, including studies of teeth from both arches and 
comparing articaine with lidocaine in a meta-analysis may lead 
to bias in the results. In addition, the results of the present 
study were in accordance with two other investigations that 
showed no significant difference between the efficacy of 
articaine with lidocaine when anesthetizing maxillary first 
molars with irreversible pulpitis [26, 27]. 
The pulpal status and the diagnosis of pulp and periapical 
disease at the time of procedure may be important issues in 
success rate of anesthesia [9]. In the present study, the pulp 
status was one of the inclusion criteria and the presence of 
bleeding upon gaining access to the pulp was essential for the 
tooth to be included in the study [43]. Therefore, one patient 
in the lidocaine group was excluded because partial pulp 
necrosis was noted once the access cavity was prepared. Based 
on the definition of various stages of the pulp and the 
periapical diseases, patients may present with symptomatic or 
asymptomatic irreversible pulpitis [44, 45]. In the present 
study, only teeth with asymptomatic irreversible pulpitis was 
included. The reason is the conflicting results of previous 
investigations when premedication with NSAIDs was used for 
evaluating their effect on anesthesia success [11, 46-49]. In fact, 
previous investigations showed conflicting results regarding 
pulpal anesthesia success rate in patients with and without 
spontaneous pain when premedication with NSAIDs was used 
[11, 46-49]. The investigations that included patients with 
spontaneous pain reported no significant difference in 
anesthesia success when the patients were used premedication 
with NSAIDs [46, 48, 49], whereas the investigations that 
included patients without spontaneous pain reported 
significantly higher success when the NSAIDs were used for 
premedication [11, 47]. As the same bias may influence the 
success rate of anesthesia again, in the present study, only 
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patients that had irreversible pulpitis but no spontaneous pain 
were included. Investigators should notice the possible bias 
and design their future research with careful inclusion criteria 
for various conditions of pulp and periapical diseases in order 
to provide more reliable results. 
In the present study, based on the multivariate logistic 
regression analysis an association between longer palatal root 
and failure to anesthesia was found. However, if someone want 
to provide a cut-off point for the palatal root length, need to do 
another research with only one anesthetic agent to provide 
sensitivity and specificity. Right now the authors are working 
on a study to find out the cut-off point using ROC analysis and 
calculating sensitivity and specificity. 
Conclusion 
The type of anesthetic solution had no significant influence on 
the success rate of anesthesia with articaine and lidocaine being 
similarly effective. However, the length of the palatal root was 
shown to adversely affect the success of anesthesia irrespective 
of the anesthetic agent used. 
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